Babiker, N.A.; Nadeem, S.; Abu Kariem, H.; Abdul Hameed, A.; Negmeldin, A.T.; El-labbad, E.M.
Medicinal Chemistry Strategies in Targeting TGF-βR1 Kinase Domain: Unveiling Insights into Inhibitor Structure–Activity Relationship (SAR). Pharmaceuticals 2025, 18, 716.
https://doi.org/10.3390/ph18050716
AMA Style
Babiker NA, Nadeem S, Abu Kariem H, Abdul Hameed A, Negmeldin AT, El-labbad EM.
Medicinal Chemistry Strategies in Targeting TGF-βR1 Kinase Domain: Unveiling Insights into Inhibitor Structure–Activity Relationship (SAR). Pharmaceuticals. 2025; 18(5):716.
https://doi.org/10.3390/ph18050716
Chicago/Turabian Style
Babiker, Nusaiba A., Soam Nadeem, Hasan Abu Kariem, Afra Abdul Hameed, Ahmed T. Negmeldin, and Eman M. El-labbad.
2025. "Medicinal Chemistry Strategies in Targeting TGF-βR1 Kinase Domain: Unveiling Insights into Inhibitor Structure–Activity Relationship (SAR)" Pharmaceuticals 18, no. 5: 716.
https://doi.org/10.3390/ph18050716
APA Style
Babiker, N. A., Nadeem, S., Abu Kariem, H., Abdul Hameed, A., Negmeldin, A. T., & El-labbad, E. M.
(2025). Medicinal Chemistry Strategies in Targeting TGF-βR1 Kinase Domain: Unveiling Insights into Inhibitor Structure–Activity Relationship (SAR). Pharmaceuticals, 18(5), 716.
https://doi.org/10.3390/ph18050716
